Nirogy Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nirogy Therapeutics's estimated annual revenue is currently $465k per year.
- Nirogy Therapeutics's estimated revenue per employee is $77,500
- Nirogy Therapeutics's total funding is $18.5M.
Employee Data
- Nirogy Therapeutics has 6 Employees.
- Nirogy Therapeutics grew their employee count by -50% last year.
Nirogy Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CSO | Reveal Email/Phone |
2 | Co-Founder | Reveal Email/Phone |
Nirogy Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Nirogy Therapeutics?
Nirogy Therapeutics is a biotechnology company based in Boston, MA developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncology as well as autoimmune diseases.
keywords:N/A
$18.5M
Total Funding
6
Number of Employees
$465k
Revenue (est)
-50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Natick
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 6 | 20% | N/A |
#2 | $0.4M | 6 | -14% | N/A |
#3 | $0.9M | 6 | -93% | N/A |
#4 | $0.9M | 6 | 0% | N/A |
#5 | $0.5M | 7 | 0% | N/A |